Skip to main content
    V

    Verastem Inc (VSTM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.70
    -0.48 (-5.87%)

    Market Cap: $1.03B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Verastem Inc (VSTM) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Verastem reported revenue of $30.91M for the fiscal year ended Dec 31, 2025, up 209.1% from the year before. That year, net income was -$209.47M with a net margin of -677.6%, operating cash flow was -$137.51M and free cash flow was -$137.51M. The quarter ended Sep 30, 2026 had revenue of $24.01M and net income of -$74.72M.

    Revenue and Margins

    Over the 7 years to Dec 2025, revenue grew from $26.72M, a compound annual rate of 2.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$30.91M+209.1%85.1%-550.3%-677.6%
    Dec 2024$10.00MN/A100.0%-1149.6%-1306.4%
    Dec 2023$0-100.0%N/AN/AN/A
    Dec 2022$2.60M+26.4%100.0%-2809.6%-2843.3%
    Dec 2021$2.05M-97.7%100.0%-2991.2%-3468.1%
    Dec 2020$88.52M+407.1%98.0%-55.8%-76.5%
    Dec 2019$17.46M-34.7%92.9%-758.1%-854.8%
    Dec 2018$26.72MN/A99.4%-354.8%-271.1%
    Dec 2017$0N/AN/AN/AN/A
    Dec 2016$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$30.91M$10.00M$0$2.60M$2.05M$88.52M$17.46M$26.72M$0$0
    Cost of revenue$4.60M$0$0$0$0$1.76M$1.24M$165.00K$0$0
    Gross profit$26.31M$10.00M$0$2.60M$2.05M$86.75M$16.22M$26.55M$0$0
    Research and development$114.60M$81.33M$61.36M$50.56M$39.35M$41.38M$45.78M$43.65M$46.42M$19.78M
    Operating income-$170.13M-$114.96M-$92.08M-$72.94M-$61.41M-$49.36M-$132.34M-$94.78M-$67.80M-$37.00M
    Net income-$209.47M-$130.64M-$87.37M-$73.81M-$71.20M-$67.73M-$149.21M-$72.43M-$67.80M-$36.44M
    EBITDAN/AN/A-$90.51M-$72.54M-$52.01M-$39.10M-$123.67M-$65.99M-$67.03M-$36.47M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$24.01M$40.08M$18.67M$17.54M$11.24M$2.14M$0-$9.98M$0$10.00M$0$114.00K
    Gross profit$20.35M$36.32M$15.90M$14.92M$9.57M$1.82M$0-$9.99M$0$10.00M$0$109.00K
    Operating income-$75.22M-$32.71M-$44.90M-$41.48M-$40.72M-$43.76M-$44.17M-$31.59M-$37.03M-$18.28M-$28.06M-$31.14M
    Net income-$74.72M-$34.67M-$36.59M-$32.92M-$98.52M-$25.93M-$52.10M-$64.55M-$23.97M-$8.26M-$33.86M-$27.37M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $76.33M by $128.66M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$246.44M$101.54M$149.72M$95.05M$108.66M$154.35M$145.05M$277.24M$89.79M$83.63M
    Current assets$223.41M$94.96M$143.68M$92.87M$105.74M$144.94M$84.96M$253.26M$87.79M$81.30M
    Cash and equivalents$204.99M$88.82M$77.91M$74.93M$21.25M$67.78M$43.51M$129.87M$82.18M$32.35M
    Total liabilities$189.25M$130.43M$71.19M$47.66M$21.10M$39.08M$137.87M$152.94M$32.11M$11.33M
    Short-term debt$0$995.00K$941.00K$1.07M$0$558.00K$420.00K$5.72M$14.83MN/A
    Long-term debt$76.33M$40.72M$40.09M$24.53M$249.00K$19.05M$103.62M$114.74M$14.83M$0
    Shareholder equity$57.20M-$28.89M$57.37M$47.39M$87.56M$115.27M$7.17M$124.30M$57.68M$72.30M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$229.64M$206.51M$227.81M$246.44M$176.85M$196.26M$131.70M$101.54M$126.38M$105.75M$105.75M$149.72M
    Total liabilities$219.54M$156.53M$146.03M$189.25M$192.38M$160.21M$164.13M$130.43M$94.16M$65.74M$65.74M$92.34M
    Cash and equivalents$172.80M$136.35M$165.55M$204.99M$137.71M$164.32M$117.57M$88.82M$113.17M$83.37M$83.37M$77.91M
    Shareholder equity$10.10M$49.99M$81.78M$57.20M-$15.53M$36.06M-$32.43M-$28.89M$11.06M$18.85M$18.85M$57.37M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$137.51M-$104.77M-$86.46M-$63.67M-$53.50M-$33.51M-$138.52M-$74.52M-$57.31M-$29.48M
    Capital expenditures$0$28.00K$0$0$196.00K$33.00K$7.00K$1.51M$1.51M$39.00K
    Free cash flow-$137.51M-$104.80M-$86.46M-$63.67M-$53.70M-$33.54M-$138.53M-$76.02M-$58.82M-$29.52M
    Dividends paidN/AN/AN/A$0$0$0$15.00KN/A$0$0
    Investing cash flow-$9.62M$59.97M-$44.45M$66.19M$87.00K-$47.36M$89.61M-$138.38M$43.95M$36.93M
    Financing cash flow$263.31M$54.78M$134.19M$51.78M$6.88M$69.63M-$2.44M$261.16M$63.18M-$5.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$33.59M-$43.91M-$52.12M-$29.95M-$36.22M-$32.66M-$38.68M-$25.10M-$23.80M-$27.57M-$28.31M-$29.68M
    Capital expendituresN/AN/A$0$1.34M$0$0$0$0$0$7.00K$21.00K$7.00K
    Free cash flowN/AN/A-$52.12M-$31.30M-$36.22M-$32.66M-$38.68M-$25.10M-$23.80M-$27.58M-$28.33M-$29.69M
    Last 12 quarters

    Frequently Asked Questions About VSTM

    What is Verastem's annual revenue?

    Verastem reported revenue of $30.91M for the fiscal year ended Dec 31, 2025.

    How fast is Verastem's revenue growing?

    Revenue was up 209.1% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Verastem profitable?

    No. Verastem reported net income of -$209.47M for the fiscal year ended Dec 31, 2025, with a net margin of -677.6%.

    How much free cash flow does VSTM generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$137.51M minus capital expenditures of $0 produced free cash flow of -$137.51M.

    How much debt does Verastem have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $76.33M, short-term debt of $0 and cash and equivalents of $204.99M.